Publications by authors named "Jonathan Feld"

Claim this Profile
R
Ring Chromosomes in Patients with Myeloid Neoplasms Are Associated with a Poor Response to Therapy.
Daniel I Nathan, Ronald Hoffman, Daiva Ahire, John Mascarenhas, Bridget K Marcellino, Vesna Najfeld, Jonathan Feld

Acta Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel 3-way translocation involving :: drives AML with eosinophilia.
Ariel Siegel, Joseph Tripodi, Dianna Hardatt, Brianna Kelly, Sebastian El Ghaity-Beckley, Jonathan Feld, Vesna Najfeld

Blood Neoplasia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matched multicenter cohort study.
Douglas Tremblay, Clifford Csizmar, Courtney D DiNardo, Somedeb Ball, Noa Rippel, Jonathan Feld

Leukemia· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia.
Metodi Balev, Victor Zibara, Grace Van Hyfte, Jonathan Feld, Marina Kremyanskaya

Am J Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database Analysis.
Serena Tharakan, Jonathan Feld, Grace Van Hyfte, John Mascarenhas, Douglas Tremblay

Clin Lymphoma Myeloma Leuk· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022.
Dahniel Sastow, Grace Van Hyfte, Jonathan Feld, Marina Kremyanskaya, John Mascarenhas

Acta Haematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights.
Shivani Handa, Kyle A Farina, Michelle Becker, Brianna Kelly, Ashley Yu, Jonathan Feld

JCO Precis Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement.
Dahniel Sastow, Joshua Tatarian, Yosef J R A Riazat-Kesh, Kyle Farina, Michelle Becker, Jonathan Feld

Leuk Lymphoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabine.
Jonathan Feld, Douglas Tremblay, Shyamala C Navada, Lewis R Silverman

Leuk Lymphoma· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.
John Cafardi, Carole Miller, Howard Terebelo, Chad Tewell, Sadia Benzaquen, Jonathan Feld

JAMA Netw Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Ringing in a new future.
Daniel I Nathan, Jonathan Feld, Siraj M El Jamal, John Mascarenhas, Douglas Tremblay

Leuk Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected pancytopenia: Dasatinib induced aplastic anemia in chronic myeloid leukemia.
Jonathan Feld, Amir Steinberg, Siraj M El Jamal, Ilan Shapira

J Oncol Pharm Pract· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study.
Sheena Bhalla, Ziad Bakouny, Andrew L Schmidt, Chris Labaki, John A Steinharter, Jonathan Feld

Lung Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia.
Douglas Tremblay, Noa Rippel, Jonathan Feld, Siraj M El Jamal, John Mascarenhas

Oncologist· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forsaken Pharmaceutical: Glasdegib in Acute Myeloid Leukemia and Myeloid Diseases.
Jonathan Feld, Lewis R Silverman, Shyamala C Navada

Clin Lymphoma Myeloma Leuk· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies.
Jonathan Feld, Douglas Tremblay, Mikaela Dougherty, Tina Czaplinska, Gillian Sanchez

Hemasphere· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis.
Jonathan Feld, Douglas Tremblay, Santiago Thibaud, Alaina Kessler, Leonard Naymagon

Int J Lab Hematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.
Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld, Maaike van Gerwen, Mathilda Alsen

Thromb Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.
Andrew L Schmidt, Ziad Bakouny, Sheena Bhalla, John A Steinharter, Douglas A Tremblay, Jonathan Feld

Cancer Cell· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients.
Douglas Tremblay, Carina Seah, Thomas Schneider, Sheena Bhalla, Jonathan Feld

Cancer Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm.
Douglas Tremblay, Jonathan Feld, Mikaela Dougherty, Tina Czaplinska, Gillian Sanchez

Leuk Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy.
Douglas Tremblay, Rafael Madero-Marroquin, Guido Lancman, Alexander Coltoff, Jonathan Feld

J Palliat Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelo-deception: Luspatercept & TGF-Beta ligand traps in myeloid diseases & anemia.
Jonathan Feld, Shyamala C Navada, Lewis R Silverman

Leuk Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
Douglas Tremblay, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud, Alaina Kessler, Jonathan Feld

Blood· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic syndromes: a review of therapeutic progress over the past 10 years.
Jonathan Feld, Abigail Belasen, Shyamala C Navada

Expert Rev Anticancer Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis